Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

BioPharma Institute Launches 5 Top U.S. Pharmaceutical & Clinical Research Industry Regulatory Compliance Courses as Parent Company Celebrates 20th Anniversary
  • USA - English


News provided by

BioPharma Institute

Sep 21, 2017, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Providing Pharmaceutical & Clinical Professionals with High Quality Training, Literature, and Certification Programs
Providing Pharmaceutical & Clinical Professionals with High Quality Training, Literature, and Certification Programs

It's an honor to serve the on-going regulatory training requirements of small to mid-sized clinical research organizations, drug manufacturers, contractors, and professionals seeking to advance rewarding careers within these important sectors.

Post this

Paramus, New Jersey (PRWEB) September 21, 2017 -- Today, BioPharma Institute, a leading training platform for highly-regulated pharmaceutical and clinical research sector professionals, has announced the addition of 5 new courses to its prospectus. These include the eagerly-awaited Regulation 21 CFR Part 11 training - Compliance with Regulation 21 CFR Part 11 on Electronic Records and Electronic Signatures (Part 11 of Title 21 of the U.S. Code of Federal Regulations for computer systems in FDA-regulated environments). The Institute’s other new courses include Introduction to Drug Safety and Pharmacovigilance, Risk Management Planning for Medicinal Products, How to Gain Approval to Market a Generic Drug in the U.S., and How to Gain Approval for Clinical Trials in the USA. These new courses join the extensive list of programs training on good manufacturing practices (GMP), good laboratory practices (GLP), and good clinical practices (GCP).

Providing many world-class training programs and courses, the BioPharma Institute is trusted by thousands of highly skilled biopharmaceutical industry professionals working in FORTUNE 500 and other corporations in the U.S., plus 10 other countries worldwide. Additionally, Continuing Professional Development (CPD) points for many of its courses are recognized by the distinguished Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom. "We're delighted with the addition of 5 courses to an already extensive list of 100+ regulatory and compliance programs," asserted Algis Rajeckas, Ph.D., Director of Marketing at the BioPharma Institute. “Given our history, our aim is to continue to exceed the expectations of biopharmaceutical and clinic research professionals."

With headquarters in Paramus, New Jersey, the BioPharma Institute, a division of GeneTree, Inc. (celebrating its 20th anniversary), was founded in 2003 to provide industry-leading training solutions for professionals that are convenient, efficient, and effective for training those working in the highly regulated pharmaceutical, biotechnology, clinical research, and healthcare industries. "There's a tremendous range of courses available concentrating on regulatory affairs, as well as performing good manufacturing, clinical, and laboratory practices for industry professionals," explained, Fardad Gharebaghi, Commercial Director, LeoPink (a BioPharma Institute Content Partner). "The BioPharma Institute stands out as a premier training portal for professionals and corporations.”

Content-rich online training programs, including automated tracking systems and managed training records, have become a hallmark of the BioPharma Institute’s advanced e-learning certification classes for companies and employees. Its goal is to constantly update and offer the finest regulatory and compliance training course options in a state-of-the-art e-learning environment. "It's an honor to serve the on-going regulatory training requirements of small to mid-sized clinical research organizations, drug manufacturers, contractors, and professionals seeking to advance rewarding careers within these important sectors," expressed, Terry Carmichael, Managing Director and Founder of GeneTree, Inc. "In the past 14 years since launching the BioPharma Institute, we provided training to customers in a total of 11 countries, across 3 continents. We look forward to the future growth of the BioPharma Institute and all of our online training participants.”

About BioPharma Institute:
Since 2003, BioPharma Institute, a division of GeneTree, Inc., established in 1997, has been a leading provider of excellence in regulatory training for thousands of professionals and corporations seeking to excel in their industries. From its base in Paramus, New Jersey, BioPharma Institute offers convenient, efficient, and effective training solutions for those working in the highly regulated pharmaceutical, clinical research, biotechnology, and healthcare industries. Trusted for over 14 years, BioPharma Institute has aggregated a comprehensive range of web-based courses, books, live and recorded seminars, and other powerful training tools. Discover the future of e-learning today by visiting biopharmainstitute.com.

Algis Rajeckas, Ph.D., BioPharma Institute, http://www.BiopharmaInstitute.com, +1 (201) 301-8370 Ext: 212, [email protected]

Modal title

Introduction to BioPharma Institute
View PDF
Introduction to BioPharma Institute
Introduction to BioPharma Institute

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.